AHA Coding Clinic® for HCPCS - 2008 Quarter 1
HCPCS code changes for drugs, biologicals and radiopharmaceuticals in CY 2008
For CY 2008, several new HCPCS codes have been created for reporting drugs and biologicals in the hospital outpatient setting. For CY 2008, several temporary C-codes have been deleted and replaced with permanent HCPCS codes. Users should pay close attention to the accurate reporting of units of service since the dosages in the new long descriptors may not correspond exactly with the long descriptors for the codes being replaced. The new CY 2008 HCPCS codes are listed below. Where applicable, the previous HCPCS codes for the new codes also are listed. Revisiting appropriate reporting of drugs and biologicals The...
Subscribe or sign in to view the full article.
Article Overview
This article explains CY 2008 HCPCS changes affecting drugs, biologicals, radiopharmaceuticals, and certain related products in the hospital outpatient setting. It also summarizes general reporting considerations for units of service, temporary-to-permanent code transitions, unlisted products, and mixed-drug scenarios. The piece is relevant to hospital coders, billing staff, and compliance personnel who need to understand the scope of the year’s HCPCS revisions and the surrounding CMS guidance.
Why This Topic Matters
Accurate HCPCS reporting affects hospital outpatient billing, unit reporting, and consistency when code descriptors or code types change from one year to the next. The article helps readers recognize which kinds of products were updated in CY 2008 and what categories of guidance accompany those changes.
Article Sections
-
Revisiting appropriate reporting of drugs and biologicals
Overview of general reporting issues for drugs and biologicals in the hospital outpatient setting. Discusses CMS reminders and broad coding considerations for accurate reporting.
-
Reporting all drugs
Addresses the expectation to report drugs and biologicals consistently, including items that may be packaged or paid differently. Focuses on general compliance considerations rather than specific code selection.
-
Reporting the number of drug units
Covers how unit-based reporting is approached for drugs and biologicals. Includes broad guidance on aligning reported units with administration and descriptor information.
-
Reporting mixed drugs
Describes general handling of mixed or compounded products in the context of HCPCS reporting. Distinguishes between commercially available combinations and other compounded situations at a high level.
-
Table 1. CY 2008 HCPCS
Presents the CY 2008 HCPCS code updates discussed in the article, including new, replaced, and related entries across drugs, biologicals, radiopharmaceuticals, and contrast materials.
What You Will Learn
- How the article frames CY 2008 HCPCS changes for outpatient drug and biological reporting.
- What general reporting topics are emphasized for unit-based billing.
- Which broad categories of products were updated in the CY 2008 table.
- How the article discusses temporary-to-permanent HCPCS changes and unlisted product reporting.
- What kinds of CMS reminders and reporting considerations are highlighted.
Who Should Read This
- Hospital outpatient coders
- Billing and revenue cycle staff
- Compliance professionals
- Health information management staff
- Coding educators and auditors
Codes Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com